Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Ankylosing Spondylitis (AS) With Etanercept

This study is to evaluate available data in Iraqi patients with ankylosing spondylitis on Enbrel treatment with regards to the impact of early treatment using data from the Baghdad Teaching Hospital registry

Inclusion Criteria:

• Diagnosed AS patients.

  • 18 years old

• Did not receive previous biological treatment for any reason

Exclusion Criteria:

• Patients previously or currently treated with other biological therapies.
• Use of etanercept for less than 1 year duration.